SLSN — Solesence Income Statement
0.000.00%
Last trade - 00:00- $89.00m
- $101.97m
- $62.06m
Annual income statement for Solesence, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 29.5 | 37.3 | 37.3 | 52.3 | 62.1 |
| Cost of Revenue | |||||
| Gross Profit | 8.69 | 8.36 | 7.83 | 16.2 | 16.1 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 26 | 39.6 | 40.8 | 47.2 | 60.5 |
| Operating Profit | 3.51 | -2.26 | -3.55 | 5.13 | 1.57 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 2.36 | -2.64 | -4.38 | 4.46 | 1.86 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 2.32 | -2.62 | -4.39 | 4.24 | 1.79 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 2.32 | -2.62 | -4.39 | 4.24 | 1.79 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 2.32 | -2.62 | -4.39 | 4.24 | 1.79 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.029 | -0.053 | -0.089 | 0.065 | 0.025 |